Owner Novartis AG

Inventors Brandl, Trixi; Raman, Prakash; Rigollier, Pascal; Seepersaud, Mohindra; Simic, Oliver

Agent Davies Collison Cave

Pub. Number AU-A-2010233472

PCT Pub. Number WO2010/116248

Priority 61/181,038 26.05.09 US; 61/168,408 10.04.09 US

Filing date 9 April 2010

Wipo publication date 14 October 2010

C07D 209/96 (2006.01) Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom

A61K 31/403 (2006.01) - condensed with carbocyclic rings, e.g. carbazole

A61P 31/22 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

C07D 401/12 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 401/14 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 403/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

C07D 403/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

C07D 405/14 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

C07D 417/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

C07K 5/08 (2006.01) Peptides having up to four amino acids in a fully defined sequence